Report cover image

Gastric Cancer Therapy Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20386813

Description

Gastric Cancer Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric cancer therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

  • Description:

    Where is the largest and fastest growing market for gastric cancer therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric cancer therapy market global report from the Business Research Company answers all these questions and many more.

    The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

  • Scope

    Markets Covered:1) By Therapy Type: Chemotherapy; Targeted Therapy; Immunotherapy; Radiation Therapy; Surgery

    2) By Drug Class: Cytotoxic Agents; Monoclonal Antibodies; Tyrosine Kinase Inhibitors; Checkpoint Inhibitors; Miscellaneous Agents

    3) By Administration Route: Oral; Intravenous; Intramuscular; Subcutaneous

    4) By Stage of Disease: Early Stage; Locally Advanced Stage; Metastatic Stage

    5) By End User: Hospitals; Oncology Clinics; Ambulatory Surgical Centers; Research Institutions; Home Care Settings

    Subsegments:

    1) By Chemotherapy: Neoadjuvant Chemotherapy (NAC); Adjuvant Chemotherapy (AC); Palliative Chemotherapy (PC); Combination Chemotherapy; Monotherapy

    2) By Targeted Therapy: Human Epidermal Growth Factor Receptor 2 (HER2) Targeted Therapy; Vascular Endothelial Growth Factor (VEGF) Inhibitors; Fibroblast Growth Factor Receptor (FGFR) Inhibitors; Mesenchymal-Epithelial Transition (MET) Inhibitors; Claudin 18 Isoform 2 Inhibitors

    3) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Adoptive Cell Transfer; Cytokine Therapy; Combination Immunotherapy

    4) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Intensity-Modulated Radiation Therapy (IMRT); Three-Dimensional Conformal Radiation Therapy (3D-CRT); Brachytherapy

    5) By Surgery: Endoscopic Mucosal Resection (EMR); Endoscopic Submucosal Dissection (ESD); Subtotal Gastrectomy; Total Gastrectomy; Lymphadenectomy

    Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca PLC; Novartis AG; GSK plc; Eli Lilly and Company; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Holdings Co. Ltd.; Astellas Pharma Inc.; Jiangsu Hengrui Pharmaceuticals Co. Ltd.; BeiGene Ltd.; Celltrion Healthcare Co. Ltd.; Hutchison MediPharma Limited; Shanghai Henlius Biotech Inc.; Imugene Limited; LintonPharm Co. Ltd.

    Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

    Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

    Time Series: Five years historic and ten years forecast.

    Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

    Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

    Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

    Delivery Format: PDF, Word and Excel Data Dashboard.

    Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

    Table of Contents

    250 Pages
    1. Executive Summary
    2. Gastric Cancer Therapy Market Characteristics
    3. Gastric Cancer Therapy Market Trends And Strategies
    4. Gastric Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
    5. Global Gastric Cancer Therapy Growth Analysis And Strategic Analysis Framework
    5.1. Global Gastric Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
    5.2. Analysis Of End Use Industries
    5.3. Global Gastric Cancer Therapy Market Growth Rate Analysis
    5.4. Global Gastric Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
    5.5. Global Gastric Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
    5.6. Global Gastric Cancer Therapy Total Addressable Market (TAM)
    6. Gastric Cancer Therapy Market Segmentation
    6.1. Global Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Chemotherapy
    Targeted Therapy
    Immunotherapy
    Radiation Therapy
    Surgery
    6.2. Global Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Cytotoxic Agents
    Monoclonal Antibodies
    Tyrosine Kinase Inhibitors
    Checkpoint Inhibitors
    Miscellaneous Agents
    6.3. Global Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Oral
    Intravenous
    Intramuscular
    Subcutaneous
    6.4. Global Gastric Cancer Therapy Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Early Stage
    Locally Advanced Stage
    Metastatic Stage
    6.5. Global Gastric Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Hospitals
    Oncology Clinics
    Ambulatory Surgical Centers
    Research Institutions
    Home Care Settings
    6.6. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Neoadjuvant Chemotherapy (NAC)
    Adjuvant Chemotherapy (AC)
    Palliative Chemotherapy (PC)
    Combination Chemotherapy
    Monotherapy
    6.7. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Human Epidermal Growth Factor Receptor 2 (HER2) Targeted Therapy
    Vascular Endothelial Growth Factor (VEGF) Inhibitors
    Fibroblast Growth Factor Receptor (FGFR) Inhibitors
    Mesenchymal-Epithelial Transition (MET) Inhibitors
    Claudin 18 Isoform 2 Inhibitors
    6.8. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Immune Checkpoint Inhibitors
    Cancer Vaccines
    Adoptive Cell Transfer
    Cytokine Therapy
    Combination Immunotherapy
    6.9. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    External Beam Radiation Therapy (EBRT)
    Intensity-Modulated Radiation Therapy (IMRT)
    Three-Dimensional Conformal Radiation Therapy (3D-CRT)
    Brachytherapy
    6.10. Global Gastric Cancer Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    Endoscopic Mucosal Resection (EMR)
    Endoscopic Submucosal Dissection (ESD)
    Subtotal Gastrectomy
    Total Gastrectomy
    Lymphadenectomy
    7. Gastric Cancer Therapy Market Regional And Country Analysis
    7.1. Global Gastric Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    7.2. Global Gastric Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    8. Asia-Pacific Gastric Cancer Therapy Market
    8.1. Asia-Pacific Gastric Cancer Therapy Market Overview
    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
    8.2. Asia-Pacific Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    8.3. Asia-Pacific Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    8.4. Asia-Pacific Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    9. China Gastric Cancer Therapy Market
    9.1. China Gastric Cancer Therapy Market Overview
    9.2. China Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
    9.3. China Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
    9.4. China Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
    10. India Gastric Cancer Therapy Market
    10.1. India Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    10.2. India Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    10.3. India Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    11. Japan Gastric Cancer Therapy Market
    11.1. Japan Gastric Cancer Therapy Market Overview
    11.2. Japan Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    11.3. Japan Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    11.4. Japan Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    12. Australia Gastric Cancer Therapy Market
    12.1. Australia Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    12.2. Australia Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    12.3. Australia Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    13. Indonesia Gastric Cancer Therapy Market
    13.1. Indonesia Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    13.2. Indonesia Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    13.3. Indonesia Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    14. South Korea Gastric Cancer Therapy Market
    14.1. South Korea Gastric Cancer Therapy Market Overview
    14.2. South Korea Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    14.3. South Korea Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    14.4. South Korea Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    15. Western Europe Gastric Cancer Therapy Market
    15.1. Western Europe Gastric Cancer Therapy Market Overview
    15.2. Western Europe Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    15.3. Western Europe Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    15.4. Western Europe Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    16. UK Gastric Cancer Therapy Market
    16.1. UK Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    16.2. UK Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    16.3. UK Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    17. Germany Gastric Cancer Therapy Market
    17.1. Germany Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    17.2. Germany Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    17.3. Germany Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    18. France Gastric Cancer Therapy Market
    18.1. France Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    18.2. France Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    18.3. France Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    19. Italy Gastric Cancer Therapy Market
    19.1. Italy Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    19.2. Italy Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    19.3. Italy Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    20. Spain Gastric Cancer Therapy Market
    20.1. Spain Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    20.2. Spain Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    20.3. Spain Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    21. Eastern Europe Gastric Cancer Therapy Market
    21.1. Eastern Europe Gastric Cancer Therapy Market Overview
    21.2. Eastern Europe Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    21.3. Eastern Europe Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    21.4. Eastern Europe Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    22. Russia Gastric Cancer Therapy Market
    22.1. Russia Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    22.2. Russia Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    22.3. Russia Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    23. North America Gastric Cancer Therapy Market
    23.1. North America Gastric Cancer Therapy Market Overview
    23.2. North America Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    23.3. North America Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    23.4. North America Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    24. USA Gastric Cancer Therapy Market
    24.1. USA Gastric Cancer Therapy Market Overview
    24.2. USA Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    24.3. USA Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    24.4. USA Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    25. Canada Gastric Cancer Therapy Market
    25.1. Canada Gastric Cancer Therapy Market Overview
    25.2. Canada Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    25.3. Canada Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    25.4. Canada Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    26. South America Gastric Cancer Therapy Market
    26.1. South America Gastric Cancer Therapy Market Overview
    26.2. South America Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    26.3. South America Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    26.4. South America Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    27. Brazil Gastric Cancer Therapy Market
    27.1. Brazil Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    27.2. Brazil Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    27.3. Brazil Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    28. Middle East Gastric Cancer Therapy Market
    28.1. Middle East Gastric Cancer Therapy Market Overview
    28.2. Middle East Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    28.3. Middle East Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    28.4. Middle East Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    29. Africa Gastric Cancer Therapy Market
    29.1. Africa Gastric Cancer Therapy Market Overview
    29.2. Africa Gastric Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    29.3. Africa Gastric Cancer Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    29.4. Africa Gastric Cancer Therapy Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
    30. Gastric Cancer Therapy Market Competitive Landscape And Company Profiles
    30.1. Gastric Cancer Therapy Market Competitive Landscape
    30.2. Gastric Cancer Therapy Market Company Profiles
    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    31. Gastric Cancer Therapy Market Other Major And Innovative Companies
    31.1. AstraZeneca PLC
    31.2. Novartis AG
    31.3. GSK plc
    31.4. Eli Lilly and Company
    31.5. Amgen Inc.
    31.6. Teva Pharmaceutical Industries Ltd.
    31.7. Otsuka Holdings Co. Ltd.
    31.8. Astellas Pharma Inc.
    31.9. Jiangsu Hengrui Pharmaceuticals Co. Ltd.
    31.10. BeiGene Ltd.
    31.11. Celltrion Healthcare Co. Ltd.
    31.12. Hutchison MediPharma Limited
    31.13. Shanghai Henlius Biotech Inc.
    31.14. Imugene Limited
    31.15. LintonPharm Co. Ltd.
    32. Global Gastric Cancer Therapy Market Competitive Benchmarking And Dashboard
    33. Key Mergers And Acquisitions In The Gastric Cancer Therapy Market
    34. Recent Developments In The Gastric Cancer Therapy Market
    35. Gastric Cancer Therapy Market High Potential Countries, Segments and Strategies
    35.1 Gastric Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities
    35.2 Gastric Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities
    35.3 Gastric Cancer Therapy Market In 2029 - Growth Strategies
    35.3.1 Market Trend Based Strategies
    35.3.2 Competitor Strategies
    36. Appendix
    36.1. Abbreviations
    36.2. Currencies
    36.3. Historic And Forecast Inflation Rates
    36.4. Research Inquiries
    36.5. The Business Research Company
    36.6. Copyright And Disclaimer
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.